CMES5 Overcoming Barriers in Type 2 Diabetes Management with Individualized Treatment Strategies

Program: CMES Ancillary Events
Clinical Session
Thursday, March 5, 2015: 6:30 PM-9:30 PM
Sapphire B (Hilton San Diego Bayfront)
**This session is eligible for CME credit**

Supported by an educational grant from sanofi-aventis U.S. Inc.

Upon completion of this educational activity, participants will be better able to:

  • Summarize current clinical findings on the benefits of early insulin initiation on long-term patient outcomes
  • Select the most appropriate basal insulin taking into consideration the various pharmacokinetics of new and emerging formulations
  • Discuss strategies to overcome barriers in initiating insulin and optimizing basal insulin therapy
  • Devise therapeutic strategies for insulin resistant patients taking into consideration new and emerging formulations of concentrated insulins
  • Discuss the benefits and limitations of emerging therapies

There is no cost to attend, however, seating is limited. Complimentary breakfast or dinner will be provided and all ENDO attendees are welcome. Priority seating will be given to Registration Ticket holders for the first 15 minutes after the advertised start time. If you have not been able to secure a Registration Ticket, the Endocrine Society will have a non-Ticket holder line for general admission to the session on a first-come, first-served basis. Register Now.

7:00 PM

Mary Ann Banerji, MD, Dept of Med, SUNY Downstate Medical Center, Brooklyn, NY
Disclosure Not Provided: MAB
7:10 PM

Mary Ann Banerji, MD, Dept of Med, SUNY Downstate Medical Center, Brooklyn, NY
Disclosure Not Provided: MAB
7:40 PM

Andrew J Ahmann, MD, Harold Schnitzer Diabetes Health Center, Oregon Health and Science University, Portland, OR
Disclosure: AJA: Study Investigator, Sanofi, Advisory Group Member, Astra Zeneca, Speaker, Novo Nordisk, Planning Group Member, Dexcom.
8:10 PM

Lisa R Tannock, MD, Internal Medicine, University of Kentucky, Lexington, KY
Nothing to Disclose: LRT
8:40 PM

John (Jack) L Leahy, MD, Endo Diab and Metab Unit, Univ of VT Coll of Med, Colchester, VT
Disclosure Not Provided: JLL
See more of: CMES Ancillary Events